Pharma channel feed – Endpoints News

Pharma channel feed

Gilead commits millions more for HIV health equity efforts in southern cities

3 years ago

Pfizer CEO Albert Bourla is putting his Covid-19 vaccine to a personal test. And so far, so good

3 years ago

Enhertu strikes again with a PhIII success in another breast cancer population

3 years ago

Do pharma TV and social ads work? Pharma marketing agencies adopting new tech solutions to find out

3 years ago

Pear Therapeutics touts Q2 growth while scaling back full-year goals and chopping 9% of staff

3 years ago

Senate Finance chair continues his investigation into pharma taxes with requests for Amgen

3 years ago

Paving the way for Merck's buyout, Seagen loses arbitration dispute with Daiichi Sankyo over ADC tech

3 years ago

FDA approves second indication for AstraZeneca and Daiichi's Enhertu in less than a week

3 years ago

J&J to remove talc products from shelves worldwide, replacing with cornstarch-based portfolio

3 years ago

CSL brings Seqirus, Vifor under parent umbrella brand in identity revamp

3 years ago

Unity finds itself with a finite amount of cash as new data provide a ray of hope for investors

3 years ago

Gold for adults, silver for infants: Pfizer's Prevnar 2.0 headed to FDA months after Merck's green light

3 years ago

Blasting 'speculative commentary,' GSK offers update on Zantac litigation and vows to 'vigorously defend itself'

3 years ago

Novartis reports two patient deaths after treatment with Zolgensma

3 years ago

Sanofi, GSK, Haleon see stock prices dip and dive amid litigation for recalled heartburn drug

3 years ago

FDA converts Novartis' NSCLC drug to a full approval with confirmatory data

3 years ago

Astellas annual cancer prize goes to mobile reporting app to bridge care gaps

3 years ago

Eli Lilly plucks a new commercial chief from Bristol Myers in management shuffle as HR chief retires

3 years ago

FDA raises questions with European data law's restrictions on reviewing clinical data

3 years ago

Amid Roche and Sanofi's oral SERD setbacks, Menarini gets speedy review at FDA

3 years ago

Pfizer launches rebate program for rare disease patients who have to stop taking Panzyga

3 years ago

Horizon readies kids and families for back to school with weeklong activities around rare disease cystinosis

3 years ago

EMA issues warning of IVF drug shortage due to manufacturing issues

3 years ago

Major drug price reforms head for Biden's signature as PhRMA weighs legal options

3 years ago

First page Previous page 180 181 182183184 185 186 Next page Last page